Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses

Single-vial thermostabilized bivalent vaccine demonstrates simultaneous protection against two lethal viruses
PRINCETON, N.J., Jan. 2, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage...

Related Keywords

United States ,Sudan ,University Of Hawaii At Manoa ,Hawaii ,Hawaiians ,Axel Lehrer ,Oreola Donini ,Prnewswire Soligenix Inc ,Department Of Tropical Medicine ,Company Public Health Solutions ,Us Development ,Our Public Health Solutions ,National Institute Of Allergy ,Soligenix Inc ,Small Business Innovation Research ,Linkedin ,Us Congress ,University Of Hawai ,Nasdaq ,Twitter ,Johna Burns School Of Medicine ,Biomedical Advanced Research ,Defense Threat Reduction Agency ,Johna Burns School Medicine ,Centers For Disease ,National Institute Of Health ,Development Authority ,Exchange Commission ,Associate Professor ,Tropical Medicine ,Medical Microbiology ,Senior Vice President ,Chief Scientific Officer ,Public Health Solutions ,National Institute ,Virus Disease ,Marburg Virus Disease ,Western Africa ,Disease Control ,Ebola Virus Disease ,Sudan Virus ,School Medicine ,Infectious Diseases ,Project Bioshield ,Priority Review Voucher ,Markets ,